The growth of the eucaryotic microorganism Dictyostelium discoideum in liquid culture was completely inhibited by the aspartic acid analog hadacidin (Nformylhydroxyamino-acetic acid). Growth arrest occurred both in chemically defined medium and in complex growth medium containing aspartic acid and AMP precursors such as adenine and adenosine. Although these compounds could not overcome the effect of hadacidin, growth was restored if cells were washed and resuspended in fresh growth medium. Additional experiments showed that D. discoideum contain adenylosuccinate synthetase, the enzyme which catalyzes the synthesis of adenylosuccinate from IMP, aspartic acid, and GTP in the de novo biosynthesis of purines. A partially purified preparation of this enzyme was obtained, and the effect of hadacidin on its activity was studied. We found that maximum inhibition of the D. discoideum activity occurs at a ratio of aspartic acid to hadacidin of 5:1, sugesting that the affinity of the drug for this enzyme is less than for the enzyme from rabbit muscle and plants but greater than for that from Escherichia coli. The effect of the drug can be overcome by a 10-fold excess of aspartic acid, suggesting that the drug acts as a competitive inhibitor. A comparison of the adenylosuccinate synthetase activity levels at various stages of growth showed that its specific activity decreases about 60% as cells enter the stationary growth phase, and decreases about 75% after starvation for 2 h. Further studies showed that in cells treated with hadacidin the rate of uptake of exogenous nutrients is reduced about 75% and that these cells are more resistant to rupture by osmotic shock. While the results ofthis study are consistent with the proposal that growth arrest is contingent upon inhibition of adenylosuccinate synthetase activity, they also suggest that, as a consequence of this inhibition, some physiological properties of the cell have been altered. Hadacidin (N-formylhydroxyamino-acetic acid), a structural analog of aspartic acid, was originally isolated from fungi (5, 7) and later found to inhibit the growth of bacteria (17), tumor cells (7, 18) , and plant tissues (5, 6). Since the results of the studies on these systems were consistent with the observation that in vitro hadacidin acted competitively with aspartic acid to inhibit adenylosuccinate (AMPS) synthetase activity (19), it was concluded that the effect of this drug in vivo was due to its inhibition of the de novo synthesis of AMP. This conclusion derived support from other studies which showed that the growth arrest and other effects produced by hadacidin could be reversed by the addition of such AMP precursors as adenine and adenosine (3, 6, 13, 15) or aspartic acid (9, 13, 15) .
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Hadacidin (N-formylhydroxyamino-acetic acid), a structural analog of aspartic acid, was originally isolated from fungi (5, 7) and later found to inhibit the growth of bacteria (17) , tumor cells (7, 18) , and plant tissues (5, 6) . Since the results of the studies on these systems were consistent with the observation that in vitro hadacidin acted competitively with aspartic acid to inhibit adenylosuccinate (AMPS) synthetase activity (19) , it was concluded that the effect of this drug in vivo was due to its inhibition of the de novo synthesis of AMP. This conclusion derived support from other studies which showed that the growth arrest and other effects produced by hadacidin could be reversed by the addition of such AMP precursors as adenine and adenosine (3, 6, 13, 15) or aspartic acid (9, 13, 15) .
In contrast to these results are those presented in this study, in which the effect of hadacidin on the growth of the eucaryotic microorganism Dictyostelium discoideum is reported. While the results of this study show that hadacidin inhibits not only the growth of this microorganism but also the activity of AMPS synthetase, which was isolated and pardally purified, they also show that the effect of the drug cannot be reversed by supplementing the growth medium with nutrients.
Attempts to explain this result led to a comparison of the AMPS synthetase activity levels at various stages of growth and after the onset of starvation. In addition, the uptake of exogenous nutrients by, and the physiological properties of, the hadacidin-treated cells were compared with those of untreated cells. While the results of this study are consistent with the view that the growth arrest of hadacidin-treated cells is a result of the inhibition of AMPS synthetase activity, they suggest that, as a result of this inhibition, physiological properties of Organisms and media. The axenic derivative (Ax-3) of D. discoideum was grown and harvested as described (16) . Cells from the exponential and stationary phases of growth were obtained by harvesting cells from HL-5 medium (see below) at densities of 1 x 106 to 2 x 106 cells per ml and 1 x 107 to 2 x 107 cells per ml, respectively. Starved cells were prepared by incubating cells harvested from the exponential growth phase in 17 mM potassium phosphate buffer (pH 6.1) containing 2 mM MgSO4 (KPM) at a cell density of 1 x 107 to 2 x 107 cells per ml (2) . The time of transfer into KPM is considered as zero time of starvation.
Chemically defined medium (FM), containing only amino acids, salts, trace metals, vitamins, and glucose, was prepared as described (4) . Complex medium (HL-5) contained essentially yeast extract, protease peptone, and glucose. The preparation (1) and composition (4) of HL-5 have been described.
Cell growth conditions. For determining the effect of hadacidin on the onset of cell growth, cells were grown to the midlog phase (1 x 106 to 2 x 106 cells per ml), the drug was added from a freshly prepared, autoclaved, stock solution, and the incubation was continued. At about 12-to 24-h intervals, samples of approximately 0.1 to 0.2 ml were removed from the cell culture, under sterile conditions, and the cell concentration was determined by cell count using a hemacytometer (Neubauer Bright Line) under x200 total magnification.
Preparation and partial purification of AMPS synthetase. Fractions enriched in AMPS synthetase activity were prepared from the psoas muscle of young rabbits by means of procedures described by Muirhead and Bishop (14) . Activity from D. discoideum was prepared in the same manner. About one pound of psoas muscle obtained from a young rabbit was minced and frozen at -20°C. For D. discoideum, approximately 1010 cells were harvested from the required stage, washed, and recovered by centrifugation, and the cell pellet was frozen at -20°C. Both the D. discoideum pellet and the minced rabbit muscle were thawed, and the cells were disrupted in a blender with 4 to 5 volumes of cold acetone. After blending at high speed for 1 to 2 min, the slurry was vacuum filtered through Whatman no. 42 filter paper. The filter cake was again disrupted in the blender with 4 to 5 volumes of cold acetone and filtered as described above. The second filter cake was air dried, and the resulting acetone powder was suspended in 50 mM KCl-1 mM dithiothreitol and stirred for 2.5 h at 4°C. Insoluble material was removed by centrifugation (30,000 x g for 20 min), and the supernatant was brought to 60 to 61°C. After 1 min, the solution was cooled to 5°C, and the insoluble material was removed by centrifugation as above. Solid ammonium sulfate was added to the supernatant fraction to obtain the protein that precipitated between 40 and 60% saturation. This material was dissolved in 50 mM KCl-1 mM dithiothreitol, dialyzed overnight against 10 volumes of the same solvent, and assayed directly for activity.
AMPS synthetase assay conditions. Enzymatic activity was assayed by using the spectrophotometric procedure described by Muirhead and Bishop (14) , modified as follows. The reaction mixture contained in a final volume of 1.0 ml: 75 ,umol of HEPES (pH 7.0), 250 nmol of IMP, 125 nmol of GTP, 8 nmol of MgCl2, and up to 600 ,ug of the partially purified enzyme preparation. After mixing, the absorbance was offset to zero, and the reaction was started by the addition of 1.25 umol of aspartic acid. The absorbance increase at 280 nm was followed continuously with a spectrophotometer (Gilford 240) and recorder. Reactions were performed at room temperature.
In some cases enzymatic activity was also assayed using a radiochemical procedure as described by Lieberman (10) . For these assays, the reaction mixture contained in a final volume of 1.5 ml: 75 ,umol of HEPES (pH 7.0) buffer, 500 umol of IMP, 625 ,umol of GTP, 1.6,umol of MgCl2, and up to 3 mg of the enzyme preparation. The reaction was started by adding 1.5 ,umol of L-[U-_4C]-aspartic acid (6 x 105 cpm/,umol).
After a 10-min incubation at room temperature, the reaction was terminated by heating the reaction mixture for 2 min in a boiling water bath. Distilled water (2 ml) was added to increase the volume, and insoluble material was removed by centrifugation (30,000 x g for 20 min). The supernatant was loaded onto a Dowex 1-X8 (20-40 mesh, chloride form) column (1 by 3 cm), and the aspartic acid was eluted with 125 ml of 0.01 N HCI, and the AMPS was eluted with 10 ml of 1 N HCI. Fractions of 1 ml were collected and assayed for radioactivity directly in Aquasol. Control experiments showed that about 85% of unlabeled authentic AMPS was eluted in the second 1-ml fraction. Therefore, for routine assays only this fraction was collected and assayed for radioactivity.
Uptake of nutrients. For these experiments, cells were grown to the midlog stage (1 x 106 to 2 x 106 cells per ml) in FM. Hadacidin-treated cells were exposed to hadacidin at a concentration of 5 mg/ml in FM for 16 Fig. 1 , indicate that hadacidin at concentrations of less than 1 mg/ml reduced the growth rate over 50% and that by 2 to 5 mg/ml growth ceased.
Since other studies had suggested that the effect of hadacidin on growth was due to its inhibition of AMP biosynthesis, this drug effect should only occur in the absence of exogenous purines. Since FM contains no purines (4), we repeated the experiments in a medium containing yeast extract and protease peptone (HL-5) to insure a source of a variety of nutrients, including purines and amino acids. The results of these experiments, shown in Fig. 1 that even when grown in this complex medium, hadacidin still inhibited growth of D. discoideum. However, the data in Fig. 1 show that in HL-5 about twice as much hadacidin was required to inhibit growth 50% as was required in FM. This result might reflect a difference in either the hadacidin uptake or in the aspartic acid-hadacidin ratio, since HL-5 contains aspartic acid (4). In additional experiments, millimolar concentrations of aspartic acid, adenine, or AMP were added to the HL-5 with no change in the results (data not shown).
To determine if the results obtained were due to a dose-dependent lysis of growing cells, samples of the cultures were taken after incubation with the drug for 24 and 48 h and, after appropriate dilution, spread on agar plates together with bacteria as a food source. After allowing 3 to 4 days for growth, the number of colonies present was determined. The number of colonies obtained was equal to the number of cells determined in the hemacytometer, indicating that all cells present were viable and that no lysis had occurred. These results suggest that inhibition of the net increase in cell number is due to an inhibition of the progress of cells through the cell cycle.
While the results of the experiments described above show that the inhibition of growth by hadacidin could not be reversed by purines, additional experiments were undertaken to determine if the drug effect could be reversed by washing the cells. For these experiments cells were incubated in HL-5 with hadacidin at 1 and 5 mg/ml. Under these conditions growth was inhibited about 25% or completely. After 48 h (Fig. 2, arrow) , the cells were harvested, using sterile techniques, and resuspended in fresh HL-5 medium without hadacidin, and the incubation was continued. Within 24 h the cell titer began to increase. However, in contrast to the behavior of the cells after treatment with 1 mg/ml, those cells treated with 5 mg/ml exhibited a considerable lag period before the growth rate approached that of the untreated cells (Fig. 2) . These results indicate that the drug can be washed out from the cells and that, with time, growth is restored, suggesting that the effect of the drug on the growth would persist only as long as the drug is present.
Demonstration of AMPS synthetase activity in D. dicoideunL To further understand the mechanisms of growth inhibition by hadacidin, we examined cell-free lysates of D. discoideum for AMPS synthetase activity. The activity obtained was extracted with KCl and further purified by heating, followed by ammonium sulfate fractionation. Figure 3 compares ics of condensation of IMP and aspartate to AMPS by this partially purified fraction with kinetics obtained using a fraction which we prepared from rabbit skeletal muscle using similar procedures. For the preparation from D. discoideum, the accumulation of product was proportional to time for about 2 min and then rapidly declined (Fig. 3, curve B) . After 10 min of incubation, about 77 mnol of product was formed, representing about 30% of the IMP originally present. In contrast, with the preparation from rabbit muscle, the activity remained constant for at least 6 min (Fig. 3, curve A) . After 10 min of incubation, the rabbit muscle preparation produced 140 nmol of AMPS, which represents about 55% of the amount of IMP initially present.
Based on the initial rates, a specific activity of 72 nmol/min per mg of protein was calculated for the D. discoideum preparation, which compares favorably with a specific activity of 63 nmol/min per mg of protein for the preparation from rabbit muscle. Using IMP, the Km for the D. discoideum enzyme was 0.35 mM, which compares favorably with that for the rabbit muscle of 0.28 mM. The reaction showed an absolute requirement for GTP, aspartate, and IMP. Activity was lost when any one of these components was omitted.
To verify the identity of the reaction product, an incubation was carried out at 10 times the scale of the assay conditions (see Materials and Methods) but with the addition of ['4C]aspartic acid as a substrate. After a 5-min incubation, the reaction was terminated by boiling, and any insoluble material was removed by centrifugation. The supematant was recovered, authentic unlabeled AMPS was added to the solution, and the mixture was applied to a Dowex column and eluted. Fractions were collected and monitored for both absorbance at 280 nm and radioactivity. The radioactive product was found to coelute with authentic AMPS.
Effect of hadacidin on D. discoideum AMPS synthetase activity. Previous studies have shown that, in a variety of systems, the aspartic acid analog hadacidin inhibits AMPS synthetase activity. As shown in For rabbit muscle, the results shown in Fig. 4 allow a ratio of 12:1 to be calculated. Additional experiments (Fig. 4) showed that increasing the aspartic acid concentration 10-fold overcame the inhibition, suggesting that hadacidin acts as a competitive inhibitor.
Comparison ofAMPS synthetase activity at different stages of growth. As part of the present study, we compared the AMPS synthetase activity obtained from exponential growth phase cells with the value obtained from cells harvested at the stationary phase of growth. As the cells entered the stationary phase the activity decreased from 0.086 ± 0.006 to 0.033 U/mg ( Table 1 ). The combining of preparations of high activity with those of lower activity always resulted in activities that were the sum of the two, suggesting that the reduction in activity is not due to the accumulation of an inhibitor.
To study the effect of starvation on AMPS synthetase activity, midexponential log growth phase cells were resuspended in a non-nutrient buffer (KPM) for 2 hours and harvested, and the AMPS synthetase activity was determined. The enzymatic activity decreased from 0.086 to 0.021 ± 002 U/mg ( Table 1) . The results of mixing experiments suggested again that the decrease in activity was not due to the presence of an inhibitor. Taken together, these results suggest that with the normal cessation of growth that accompanies starvation, there is a decrease in the activity of this enzyme.
Effect of hadacidin on cell uptake. Since one possible explanation for the failure of exogenous substances like aspartic acid or purines to restore growth to hadacidin-treated cells might be related to their failure to be taken up, the incorporation of two representative compounds, aspartic acid and thymine, into hadacidintreated cells was determined. Neither of these nutrients is present in FM.
For these experiments, celLs were incubated with 5 mg of hadacidin per ml for 18 mined (see Materials and Methods). The rate of incorporation of both compounds remained constant for at least 2 h. In Table 2 , we compare the rates of incorporation of thymine and aspartic acid into both treated and untreated cells. The presence of hadacidin reduced the rate of incorporation of both substances by at least 75%, suggesting that the uptake of nutrients by the cells had been affected by the drug.
Effect of hadacidin on osmotic stability of D. discoideunL While the results described above indicated that hadacidin treatment reduces the uptake of extracellular constituents, it remained to be shown whether or not this finding could reflect a change in the properties of the cell membrane. To study this question we took advantage of an observation, made during the course of this study, that hadacidin-treated cells were more resistant to cell lysis. Since this result is consistent with the idea that the drug causes a change in the osmotic properties of the cell, we decided to try to measure this change by challenging hadacidin-treated cells with amphotericin B, a technique which we previously showed to induce osnotic instability (16) .
For these experiments, hadacidin-treated cells were incubated with amphotericin B for several hours. At intervals during this time, samples were removed from both treated and controls (no hadacidin treatment), and, after diluting into glass-distilled water, the number of cells remaining unlysed was determined microscopically. Although in both cases the number of cells lysed increased during the 3-h incubation period, the rate of cell lysis for treated cells was less than for untreated cells (Table 3) . Thus, after 3 h over 99% of the untreated cells were lysed, whereas after hadacidin treatment only about 50% of the cells were lysed, suggesting that hadacidin treatment can alter the osmotic properties of the cell. DISCUSSION While these data show that hadacidin inhibits growth in a medium that does not contain purines (chemically defined medium), they also show that inhibition of growth occurs in a medium containing a rich source of exogenous nutrients (complex medium). This latter result seemed rather surprising because of numerous reports of the reversal of the growth inhibition of hadacidin following the addition of purines, especially adenine or adenosine (3, 6, 13, 15) and aspartic acid (9, 13, 15) .
Additional experiments showed that the drug could be washed out and, as a consequence, growth could be restored, strongly suggesting that the inhibition of growth is a direct effect of the drug rather than the result of a series of minor changes initiated by hadacidin. This wash-out experiment also suggests that the drug is not degraded by either intra-or extracellular reactions.
To study this growth arrest further, we felt it necessary to demonstrate an AMPS synthetase activity in D. discoideum. Accordingly, we identified and partially purified both such an activity from this microorganism and, to establish the validity of our procedures and assays, the enzyme previously identified in rabbit skeletal muscle (14) as well. The results of experiments with the partially purified preparation from D. discoideum showed that hadacidin inhibited the activity at an aspartic acid-hadacidin ratio of 5:1, a result to be compared with the 12:1 ratio *that we obtained for the preparation from rabbit muscle. This difference suggests that the affinity of the enzyme from D. discoideum for hadacidin is less than that of the rabbit muscle enzyme.
While these results suggest that the inhibition of growth by hadacidin might be explained in terms of its inhibition of AMPS synthetase and subsequent cessation of the de novo synthesis of AMP, they do not explain why this effect was not reversed by the addition of exogenous purines. One possible explanation involves a consideration of the special relationship that exists in D. discoideum between growth and cellular differentiation. With this microorganism, either the cessation of growth that occurs at stationary phase or the growth arrest that follows starvation initiates a series of biochemical and morphological changes which together result in the differentiation ofwhat was originally a collection of identical cells. Although it is not at all clear how the cessation of growth initiates cellular VOL. 14, 1978 on October 16, 2017 by guest http://aac.asm.org/ 482 ROSSOMANDO, MALDONADO, AND CREAN differentiation, the deprivation of specific amino acids appears to be involved in this process (12) . In an attempt to establish a connection between purine biosynthesis and the initiation of cellular differentiation, we determined the level of AMPS synthetase in cells harvested both after the cessation of growth at stationary phase and after starvation. In both cases we found that the specific activity of this enzyme was less than that observed in growing cells. Since, after the cessation of growth, there are both a cessation of DNA synthesis (8, 11 ) and a decrease in RNA content (1, 20) , we might expect that the demand for purines would decline and could now be met by catabolic processes. The decline in activity of enzymes associated with the de novo pathway is consistent with this expectation.
Another possible explanation for the failure of exogenous nutrients to reverse the drug arrest would be that, as a consequence of the decrease in AMPS synthetase activity, the properties of the cell have been altered, with the result that exogenous nutrients cannot be taken up. This explanation derives support from our results, which show not only that drug treatment reduces the rate of incorporation of exogenous nutrients but also that the osmotic properties of the cell membrane have been altered. Thus, the growth inhibition produced by hadacidin may initiate physiological changes similar to those which occur during the normal cessation of growth that accompanies stationary phase or starvation. Both the normal and abnormal processes of growth arrest share the common feature that they are accompanied by a loss of AMPS synthetase activity and an increase in osmotic stability.
